Coccidioidomycosis Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Jun 2026A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

University of Southern California — NA

TrialNOT YET RECRUITING

Mar 2026Olorofim in Early Coccidioidal Meningitis

Fariba Donovan — PHASE2

TrialNOT YET RECRUITING

Mar 2026The Effect of Grocery Support Dose on Food Insecurity and Disease Control Among Covered California Members With Diabetes or Hypertension

University of California, San Francisco — NA

TrialNOT YET RECRUITING

Mar 2026RCT of HeartBot in Women

University of California, San Francisco — NA

TrialNOT YET RECRUITING

Jan 2026A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia

Pfizer

TrialACTIVE NOT RECRUITING

Dec 2025California MEPS Hub

University of California, Los Angeles — NA

TrialRECRUITING

Nov 2025Role of Circulating MicroRNAs in Differentiating Psychological Disorders Among Women With Chronic Toxoplasmosis

Benha University

TrialRECRUITING

Sep 2025Isolated Positive Toxoplasma Gondii PCR in Blood

University Hospital, Clermont-Ferrand

TrialNOT YET RECRUITING

Jul 2025Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)

University of Oxford — PHASE2

TrialACTIVE NOT RECRUITING

Apr 2025Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011

IDBiologics, Inc. — PHASE1

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Rebyota

Ferring Pharmaceuticals, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Rebyota

(fecal microbiota, live - jslm)Orphan drugstandard

Ferring Pharmaceuticals, Inc.

12.1 Mechanism of Action The mechanism of action of REBYOTA has not been established.

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

5 active trials

2Phase 2

1Phase 1

1N/A

1Unknown

5Total recruiting

Search clinical trials for Coccidioidomycosis →

Recent News & Research

No recent news articles indexed yet for Coccidioidomycosis.
Search PubMed for Coccidioidomycosis →

Browse all Coccidioidomycosis news →

Specialist Network

Top 6 by expertise

Andrej Spec, MD

Washington University School of Medicine

📍 SAINT LOUIS, MO

Score 212 trials1 pub

Peter G Pappas, MD

University of Alabama at Birmingham

Score 141 trial

Sofiati Dian, M.D., PhD

Faculty of Medicine Universitas Padjadjaran Bandung

Score 81 trial

Steven M Holland, M.D.

National Institutes of Health Clinical Center (CC)

Score 75 trials

Joel Palefsky, MD

AIDS Malignancy Consortium

📍 SAN FRANCISCO, CA

Score 66 trials

Phillip Pittman, MD, M.D

USAMRIID Medical Division

📍 WASHINGTON, DC

Score 41 trial

View all Coccidioidomycosis specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰